Influence of diabetes mellitus, hypercholesterolemia, and their combination on EDHF-mediated responses in mice

J Cardiovasc Pharmacol. 2005 May;45(5):485-90. doi: 10.1097/01.fjc.0000159657.93922.cb.

Abstract

The endothelium synthesizes and releases several vasodilator substances, including vasodilator prostaglandins, NO, and EDHF. NO-mediated relaxations are reduced by various risk factors, such as diabetes mellitus and hypercholesterolemia. However, it remains to be elucidated whether EDHF-mediated relaxations also are reduced by those factors and their combination. In this study, we addressed this point in mice. We used small mesenteric arteries from control, diabetic (streptozotocin-induced), apolipoprotein-E-deficient (ApoE-/-), and diabetic ApoE-/- mice. In control mice, endothelium-dependent relaxations to acetylcholine were largely mediated by EDHF. This EDHF-mediated component was slightly reduced in diabetic mice, preserved in ApoE-/- mice, and markedly reduced in diabetic ApoE-/- mice with an increase in NO-mediated component and a negative contribution of indomethacin-sensitive endothelium-derived contracting factor (EDCF). Endothelium-independent relaxations to sodium nitroprusside or NS1619, a direct opener of calcium-activated K channels, were attenuated in ApoE-/- and diabetic ApoE-/- mice. Endothelium-dependent hyperpolarizations were significantly reduced in diabetic mice, preserved in ApoE-/- mice, and again markedly reduced in diabetic ApoE-/- mice. These results indicate that hypercholesterolemia alone minimally affects the EDHF-mediated relaxations, and diabetes mellitus significantly attenuated the responses, whereas their combination markedly attenuates the responses with a compensatory involvement of NO and a negative contribution of EDCF.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcholine / pharmacology
  • Animals
  • Apolipoproteins E / deficiency
  • Benzimidazoles / pharmacology
  • Biological Factors / physiology*
  • Blood Glucose / analysis
  • Diabetes Mellitus, Experimental / physiopathology*
  • Dose-Response Relationship, Drug
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / physiology
  • Endothelium-Dependent Relaxing Factors / pharmacology
  • Hypercholesterolemia / physiopathology*
  • Lipids / blood
  • Membrane Potentials / drug effects
  • Mesenteric Arteries / drug effects
  • Mesenteric Arteries / physiology
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Nitric Oxide / pharmacology
  • Nitroprusside / pharmacology
  • Potassium Channels / physiology
  • Vasodilation / drug effects
  • Vasodilation / physiology*
  • Vasodilator Agents / pharmacology

Substances

  • Apolipoproteins E
  • Benzimidazoles
  • Biological Factors
  • Blood Glucose
  • Endothelium-Dependent Relaxing Factors
  • Lipids
  • Potassium Channels
  • Vasodilator Agents
  • endothelium-dependent hyperpolarization factor
  • NS 1619
  • Nitroprusside
  • Nitric Oxide
  • Acetylcholine